Independent Strategic Advisory
CAPEX Risk & Governance for Aseptic Fill-Finish
Independent, experience-based support for pharmaceutical companies and OEMs working with isolators, RABS, aseptic processes, Annex 1 expectations and complex fill-finish projects.
Where early decisions matter
URS clarity, barrier strategy, transfer technology, FAT/SAT readiness, contamination control and lifecycle capability.
Founder & Principal
Independent judgment built across pharma, OEM and technology roles
Juergen M. Metzger brings experience spanning three decades in pharmaceutical equipment, aseptic fill-finish, barrier technology, automation and complex CAPEX projects.
His cross-functional perspective helps identify interface, lifecycle and execution risks early—before they become expensive project changes.
Strategic Advisory
Senior-level support for project strategy, risk reduction and governance.
02Barrier Systems
Isolators, RABS, transfer technology and practical Annex 1 alignment.
03Knowledge Base
Technical resources from the existing Pharma-Technology-Consulting knowledge base.